Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$39.12 USD
+0.15 (0.38%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $39.10 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $0.69 | -5.80% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.82 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for HALO's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of $0.69 per share, reflecting a year-over-year increase of 46.81%.
Earnings History
Price & Consensus
Zacks News for HALO
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services